Home > > > > > Report Detail

Global Liraglutide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 15-Sep-2022
No. of pages: 109
Inquire Before Buying

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Liraglutide market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

China Liraglutide market size was US$ million in 2021, while the US and Europe Liraglutide were US$ million and US$ million, severally. The proportion of the US was % in 2021, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Liraglutide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global main manufacturers of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In 2021, the global five largest players have a share approximately % in terms of volume.

In 2021, Pills segment accounted for a share of % in the global Liraglutide market. And this product segment is poised to reach US$ million by 2028 from US$ million in 2021.

In Liraglutide market, the Hospital segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2028, at a CAGR of % during 2022 and 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liraglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Liraglutide.

The Liraglutide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Liraglutide market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liraglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- HEC Pharm

- Bachem

- Bharat Pharmaceuticals

- Kingpep Biotechnology

- Shenzhen JYMed Technology

- Wuxi Asiapeptide

- AmbioPharm

Product Type Insights

Global markets are presented by Liraglutide type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Liraglutide are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Liraglutide Segment by Type

- Pills

- Liquid

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Liraglutide market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Liraglutide market.

Liraglutide Segment by Application

- Hospital

- Drug Store

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Liraglutide market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liraglutide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Liraglutide and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Liraglutide industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liraglutide

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Liraglutide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Liraglutide Product Introduction
1.2 Market by Type
1.2.1 Global Liraglutide Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Pills
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Liraglutide Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liraglutide Market Size Estimates and Forecasts
2.1.1 Global Liraglutide Revenue 2017-2028
2.1.2 Global Liraglutide Sales 2017-2028
2.2 Liraglutide Market Size by Region: 2022 Versus 2028
2.3 Liraglutide Sales by Region (2017-2028)
2.3.1 Global Liraglutide Sales by Region: 2017-2022
2.3.2 Global Liraglutide Sales Forecast by Region (2023-2028)
2.3.3 Global Liraglutide Sales Market Share by Region (2017-2028)
2.4 Liraglutide Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Liraglutide Revenue by Region: 2017-2022
2.4.2 Global Liraglutide Revenue Forecast by Region (2023-2028)
2.4.3 Global Liraglutide Revenue Market Share by Region (2017-2028)
3 Global Liraglutide by Manufacturers
3.1 Global Top Liraglutide Manufacturers by Sales
3.1.1 Global Liraglutide Sales by Manufacturer (2017-2022)
3.1.2 Global Liraglutide Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Liraglutide Manufacturers by Revenue
3.2.1 Global Liraglutide Revenue by Manufacturer (2017-2022)
3.2.2 Global Liraglutide Revenue Share by Manufacturer (2017-2022)
3.3 Global Liraglutide Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Liraglutide Manufacturers Covered: Ranking by Revenue
3.4.2 Global Liraglutide Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Liraglutide Manufacturing Base Distribution, Product Type
3.5.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Liraglutide Product Type
3.5.3 Date of International Manufacturers Enter into Liraglutide Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 HEC Pharm
4.1.1 HEC Pharm Corporation Information
4.1.2 HEC Pharm Description, Business Overview
4.1.3 HEC Pharm Liraglutide Products Offered
4.1.4 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.1.5 HEC Pharm Liraglutide Sales by Product in 2021
4.1.6 HEC Pharm Liraglutide Sales by Application in 2021
4.1.7 HEC Pharm Liraglutide Sales by Geographic Area in 2021
4.1.8 HEC Pharm Recent Developments
4.2 Bachem
4.2.1 Bachem Corporation Information
4.2.2 Bachem Description, Business Overview
4.2.3 Bachem Liraglutide Products Offered
4.2.4 Bachem Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Bachem Liraglutide Sales by Product in 2021
4.2.6 Bachem Liraglutide Sales by Application in 2021
4.2.7 Bachem Liraglutide Sales by Geographic Area in 2021
4.2.8 Bachem Recent Developments
4.3 Bharat Pharmaceuticals
4.3.1 Bharat Pharmaceuticals Corporation Information
4.3.2 Bharat Pharmaceuticals Description, Business Overview
4.3.3 Bharat Pharmaceuticals Liraglutide Products Offered
4.3.4 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bharat Pharmaceuticals Liraglutide Sales by Product in 2021
4.3.6 Bharat Pharmaceuticals Liraglutide Sales by Application in 2021
4.3.7 Bharat Pharmaceuticals Liraglutide Sales by Geographic Area in 2021
4.3.8 Bharat Pharmaceuticals Recent Developments
4.4 Kingpep Biotechnology
4.4.1 Kingpep Biotechnology Corporation Information
4.4.2 Kingpep Biotechnology Description, Business Overview
4.4.3 Kingpep Biotechnology Liraglutide Products Offered
4.4.4 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Kingpep Biotechnology Liraglutide Sales by Product in 2021
4.4.6 Kingpep Biotechnology Liraglutide Sales by Application in 2021
4.4.7 Kingpep Biotechnology Liraglutide Sales by Geographic Area in 2021
4.4.8 Kingpep Biotechnology Recent Developments
4.5 Shenzhen JYMed Technology
4.5.1 Shenzhen JYMed Technology Corporation Information
4.5.2 Shenzhen JYMed Technology Description, Business Overview
4.5.3 Shenzhen JYMed Technology Liraglutide Products Offered
4.5.4 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Shenzhen JYMed Technology Liraglutide Sales by Product in 2021
4.5.6 Shenzhen JYMed Technology Liraglutide Sales by Application in 2021
4.5.7 Shenzhen JYMed Technology Liraglutide Sales by Geographic Area in 2021
4.5.8 Shenzhen JYMed Technology Recent Developments
4.6 Wuxi Asiapeptide
4.6.1 Wuxi Asiapeptide Corporation Information
4.6.2 Wuxi Asiapeptide Description, Business Overview
4.6.3 Wuxi Asiapeptide Liraglutide Products Offered
4.6.4 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Wuxi Asiapeptide Liraglutide Sales by Product in 2021
4.6.6 Wuxi Asiapeptide Liraglutide Sales by Application in 2021
4.6.7 Wuxi Asiapeptide Liraglutide Sales by Geographic Area in 2021
4.6.8 Wuxi Asiapeptide Recent Development
4.7 AmbioPharm
4.7.1 AmbioPharm Corporation Information
4.7.2 AmbioPharm Description, Business Overview
4.7.3 AmbioPharm Liraglutide Products Offered
4.7.4 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2017-2022)
4.7.5 AmbioPharm Liraglutide Sales by Product in 2021
4.7.6 AmbioPharm Liraglutide Sales by Application in 2021
4.7.7 AmbioPharm Liraglutide Sales by Geographic Area in 2021
4.7.8 AmbioPharm Recent Development
5 Breakdown Data by Type
5.1 Global Liraglutide Sales by Type (2017-2028)
5.1.1 Global Liraglutide Sales by Type (2017-2022)
5.1.2 Global Liraglutide Sales Forecast by Type (2023-2028)
5.1.3 Global Liraglutide Sales Market Share by Type (2017-2028)
5.2 Global Liraglutide Revenue Forecast by Type (2017-2028)
5.2.1 Global Liraglutide Revenue by Type (2017-2022)
5.2.2 Global Liraglutide Revenue Forecast by Type (2023-2028)
5.2.3 Global Liraglutide Revenue Market Share by Type (2017-2028)
5.3 Liraglutide Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Liraglutide Sales by Application (2017-2028)
6.1.1 Global Liraglutide Sales by Application (2017-2022)
6.1.2 Global Liraglutide Sales Forecast by Application (2023-2028)
6.1.3 Global Liraglutide Sales Market Share by Application (2017-2028)
6.2 Global Liraglutide Revenue Forecast by Application (2017-2028)
6.2.1 Global Liraglutide Revenue by Application (2017-2022)
6.2.2 Global Liraglutide Revenue Forecast by Application (2023-2028)
6.2.3 Global Liraglutide Revenue Market Share by Application (2017-2028)
6.3 Liraglutide Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Liraglutide Market Size YoY Growth 2017-2028
7.2 North America Liraglutide Market Facts & Figures by Country
7.2.1 North America Liraglutide Sales by Country (2017-2028)
7.2.2 North America Liraglutide Revenue by Country (2017-2028)
7.3 North America Liraglutide Sales by Type
7.4 North America Liraglutide Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Liraglutide Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Liraglutide Market Facts & Figures by Region
8.2.1 Asia-Pacific Liraglutide Sales by Region (2017-2028)
8.2.2 Asia-Pacific Liraglutide Revenue by Region (2017-2028)
8.3 Asia-Pacific Liraglutide Sales by Type
8.4 Asia-Pacific Liraglutide Sales by Application
9 Europe
9.1 Europe Liraglutide Market Size YoY Growth 2017-2028
9.2 Europe Liraglutide Market Facts & Figures by Country
9.2.1 Europe Liraglutide Sales by Country (2017-2028)
9.2.2 Europe Liraglutide Revenue by Country (2017-2028)
9.3 Europe Liraglutide Sales by Type
9.4 Europe Liraglutide Sales by Application
10 Latin America
10.1 Latin America Liraglutide Market Size YoY Growth 2017-2028
10.2 Latin America Liraglutide Market Facts & Figures by Country
10.2.1 Latin America Liraglutide Sales by Country (2017-2028)
10.2.2 Latin America Liraglutide Revenue by Country (2017-2028)
10.3 Latin America Liraglutide Sales by Type
10.4 Latin America Liraglutide Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Liraglutide Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Liraglutide Market Facts & Figures by Country
11.2.1 Middle East and Africa Liraglutide Sales by Country (2017-2028)
11.2.2 Middle East and Africa Liraglutide Revenue by Country (2017-2028)
11.3 Middle East and Africa Liraglutide Sales by Type
11.4 Middle East and Africa Liraglutide Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Liraglutide Supply Chain Analysis
12.2 Liraglutide Key Raw Materials and Upstream Suppliers
12.3 Liraglutide Clients Analysis
12.4 Liraglutide Sales Channel and Sales Model Analysis
12.4.1 Liraglutide Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Liraglutide Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Liraglutide Distributors
13 Market Dynamics
13.1 Liraglutide Industry Trends
13.2 Liraglutide Market Drivers
13.3 Liraglutide Market Challenges
13.4 Liraglutide Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Liraglutide Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Pills
Table 3. Major Manufacturers of Liquid
Table 4. Global Liraglutide Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Liraglutide Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Liraglutide Sales by Region (2017-2022) & (K MT)
Table 7. Global Liraglutide Sales Forecast by Region (2023-2028) & (K MT)
Table 8. Global Liraglutide Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Liraglutide Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Liraglutide Sales by Manufacturer (2017-2022) & (K MT)
Table 11. Global Liraglutide Sales Share by Manufacturer (2017-2022)
Table 12. Liraglutide Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Liraglutide Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Liraglutide Price (2017-2022) & (USD/MT)
Table 15. Ranking of Global Top Liraglutide Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liraglutide as of 2021)
Table 18. Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Liraglutide Product Type
Table 20. Date of International Manufacturers Enter into Liraglutide Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. HEC Pharm Corporation Information
Table 23. HEC Pharm Description and Business Overview
Table 24. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 25. HEC Pharm Liraglutide Product
Table 26. HEC Pharm Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 27. HEC Pharm Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 28. HEC Pharm Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 29. HEC Pharm Recent Development
Table 30. Bachem Corporation Information
Table 31. Bachem Description and Business Overview
Table 32. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 33. Bachem Liraglutide Product
Table 34. Bachem Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 35. Bachem Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 36. Bachem Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 37. Bachem Recent Development
Table 38. Bharat Pharmaceuticals Corporation Information
Table 39. Bharat Pharmaceuticals Description and Business Overview
Table 40. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 41. Bharat Pharmaceuticals Liraglutide Product
Table 42. Bharat Pharmaceuticals Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 43. Bharat Pharmaceuticals Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 44. Bharat Pharmaceuticals Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 45. Bharat Pharmaceuticals Recent Development
Table 46. Kingpep Biotechnology Corporation Information
Table 47. Kingpep Biotechnology Description and Business Overview
Table 48. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 49. Kingpep Biotechnology Liraglutide Product
Table 50. Kingpep Biotechnology Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 51. Kingpep Biotechnology Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 52. Kingpep Biotechnology Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 53. Kingpep Biotechnology Recent Development
Table 54. Shenzhen JYMed Technology Corporation Information
Table 55. Shenzhen JYMed Technology Description and Business Overview
Table 56. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 57. Shenzhen JYMed Technology Liraglutide Product
Table 58. Shenzhen JYMed Technology Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 59. Shenzhen JYMed Technology Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 60. Shenzhen JYMed Technology Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 61. Shenzhen JYMed Technology Recent Development
Table 62. Wuxi Asiapeptide Corporation Information
Table 63. Wuxi Asiapeptide Description and Business Overview
Table 64. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Wuxi Asiapeptide Liraglutide Product
Table 66. Wuxi Asiapeptide Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 67. Wuxi Asiapeptide Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 68. Wuxi Asiapeptide Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 69. AmbioPharm Corporation Information
Table 70. AmbioPharm Description and Business Overview
Table 71. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 72. AmbioPharm Liraglutide Product
Table 73. AmbioPharm Liraglutide Sales Proportion of Liraglutide by Product in 2021
Table 74. AmbioPharm Liraglutide Sales Proportion of Liraglutide by Application in 2021
Table 75. AmbioPharm Liraglutide Sales Proportion of Liraglutide by Geographic Area in 2021
Table 76. Global Liraglutide Sales by Type (2017-2022) & (K MT)
Table 77. Global Liraglutide Sales Forecast by Type (2023-2028) & (K MT)
Table 78. Global Liraglutide Revenue by Type (2017-2022) & (US$ Million)
Table 79. Global Liraglutide Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 80. Global Liraglutide Sales by Application (2017-2022) & (K MT)
Table 81. Global Liraglutide Sales Forecast by Application (2023-2028) & (K MT)
Table 82. Global Liraglutide Revenue by Application (2017-2022) & (US$ Million)
Table 83. Global Liraglutide Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 84. North America Liraglutide Sales by Country (2017-2022) & (K MT)
Table 85. North America Liraglutide Sales by Country (2023-2028) & (K MT)
Table 86. North America Liraglutide Revenue by Country (2017-2022) & (US$ Million)
Table 87. North America Liraglutide Revenue by Country (2023-2028) & (US$ Million)
Table 88. North America Liraglutide Sales by Type (2017-2022) & (K MT)
Table 89. North America Liraglutide Sales by Application (2017-2022) & (K MT)
Table 90. Asia-Pacific Liraglutide Sales by Region (2017-2022) & (K MT)
Table 91. Asia-Pacific Liraglutide Sales by Region (2023-2028) & (K MT)
Table 92. Asia-Pacific Liraglutide Revenue by Region (2017-2028) & (US$ Million)
Table 93. Asia-Pacific Liraglutide Revenue by Region (2023-2028) & (US$ Million)
Table 94. Asia-Pacific Liraglutide Sales by Type (2017-2022) & (K MT)
Table 95. Asia-Pacific Liraglutide Sales by Application (2017-2022) & (K MT)
Table 96. Europe Liraglutide Sales by Country (2017-2022) & (K MT)
Table 97. Europe Liraglutide Sales by Country (2023-2028) & (K MT)
Table 98. Europe Liraglutide Revenue by Country (2017-2022) & (US$ Million)
Table 99. Europe Liraglutide Revenue by Country (2023-2028) & (US$ Million)
Table 100. Europe Liraglutide Sales by Type (2017-2022) & (K MT)
Table 101. Europe Liraglutide Sales by Application (2017-2022) & (K MT)
Table 102. Latin America Liraglutide Sales by Country (2017-2022) & (K MT)
Table 103. Latin America Liraglutide Sales by Country (2023-2028) & (K MT)
Table 104. Latin America Liraglutide Revenue by Country (2017-2022) & (US$ Million)
Table 105. Latin America Liraglutide Revenue by Country (2023-2028) & (US$ Million)
Table 106. Latin America Liraglutide Sales by Type (2017-2022) & (K MT)
Table 107. Latin America Liraglutide Sales by Application (2017-2022) & (K MT)
Table 108. Middle East and Africa Liraglutide Sales by Country (2017-2022) & (K MT)
Table 109. Middle East and Africa Liraglutide Sales by Country (2023-2028) & (K MT)
Table 110. Middle East and Africa Liraglutide Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Liraglutide Revenue by Country (2023-2028) & (US$ Million)
Table 112. Middle East and Africa Liraglutide Sales by Type (2017-2022) & (K MT)
Table 113. Middle East and Africa Liraglutide Sales by Application (2017-2022) & (K MT)
Table 114. Liraglutide Key Raw Materials, Industry Status and Trend
Table 115. Liraglutide Key Raw Materials and Upstream Suppliers
Table 116. Liraglutide Clients Status and Trend
Table 117. Liraglutide Typical Clients
Table 118. Liraglutide Distributors
Table 119. Liraglutide Market Trends
Table 120. Liraglutide Market Drivers
Table 121. Liraglutide Market Challenges
Table 122. Liraglutide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Market Share by Type in 2021 & 2028
Figure 3. Pills Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Liraglutide Sales Market Share by Application in 2021 & 2028
Figure 6. Hospital Examples
Figure 7. Drug Store Examples
Figure 8. Liraglutide Report Years Considered
Figure 9. Global Liraglutide Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Liraglutide Market Size 2017-2028 (US$ Million)
Figure 11. Global Liraglutide Sales 2017-2028 (K MT)
Figure 12. Global Liraglutide Market Size Market Share by Region: 2022 Versus 2028
Figure 13. Global Liraglutide Sales Market Share Forecast by Region (2017-2028)
Figure 14. Global Liraglutide Revenue Market Share by Region (2017-2028)
Figure 15. Global Liraglutide Sales Share by Manufacturer in 2021
Figure 16. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Liraglutide Sales Market Share Forecast by Type (2017-2028)
Figure 18. Global Liraglutide Revenue Market Share Forecast by Type (2017-2028)
Figure 19. Liraglutide Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
Figure 20. Global Liraglutide Sales Market Share Forecast by Application (2017-2028)
Figure 21. Global Liraglutide Revenue Market Share Forecast by Application (2017-2028)
Figure 22. Liraglutide Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
Figure 23. North America Liraglutide Revenue 2017-2028 (US$ Million)
Figure 24. North America Liraglutide Sales Market Share by Type (2017-2022)
Figure 25. North America Liraglutide Sales Market Share by Application (2017-2022)
Figure 26. Asia-Pacific Liraglutide Revenue 2017-2028 (US$ Million)
Figure 27. Asia-Pacific Liraglutide Sales Market Share by Region (2017-2028)
Figure 28. Asia-Pacific Liraglutide Revenue Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Liraglutide Sales Market Share by Type (2017-2022)
Figure 30. Asia-Pacific Liraglutide Sales Market Share by Application (2017-2022)
Figure 31. Europe Liraglutide Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Europe Liraglutide Sales Market Share by Country (2017-2028)
Figure 33. Europe Liraglutide Revenue Market Share by Country (2017-2028)
Figure 34. Europe Liraglutide Sales Market Share by Type (2017-2022)
Figure 35. Europe Liraglutide Sales Market Share by Application (2017-2022)
Figure 36. Latin America Liraglutide Revenue Growth Rate 2017-2028 (US$ Million)
Figure 37. Latin America Liraglutide Sales Market Share by Country (2017-2028)
Figure 38. Latin America Liraglutide Revenue Market Share by Country (2017-2022)
Figure 39. Latin America Liraglutide Sales Market Share by Type (2017-2022)
Figure 40. Latin America Liraglutide Sales Market Share by Application (2017-2022)
Figure 41. Middle East and Africa Liraglutide Revenue Growth Rate 2017-2028 (US$ Million)
Figure 42. Middle East and Africa Liraglutide Sales Market Share by Country (2017-2028)
Figure 43. Middle East and Africa Liraglutide Revenue Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Liraglutide Sales Market Share by Type (2017-2022)
Figure 45. Middle East and Africa Liraglutide Sales Market Share by Application (2017-2022)
Figure 46. Liraglutide Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Liraglutide Raw Materials by Region in 2021
Figure 48. Liraglutide Distribution Channels
Figure 49. Global Liraglutide Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 50. Global Liraglutide Percentage 2017-2028: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs